HX008
AssetAntibody
Monoclonal antibody targeting PD-1
- Stage
- Phase 2
- Modality
- Antibody
- Target
- PDCD1
- Indications
- 2
- Trials
- 1,991
- Developers
- 1
Indications
2Nonsquamous non small cell lung cancer
Phase 2UNKNOWNNCT04750083clinicaltrials.gov7 Oct 2026
Triple-negative breast cancer
Phase 1UNKNOWNNCT04750382clinicaltrials.gov7 Oct 2026
- Targets and what it contains2
- Owner and partners1
- Trials1,991
- Evidence for its targets2
- Competitors12
- Signals15
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 3 sources